Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
BBC Russian Subscribe
Spotlight

Vaccines

Latest News
December 29th 2023

Vaccines Reduce Declines in Respiratory Parameters Post COVID-19 Among Health Care Workers

December 27th 2023

Electronic 'Nudges' to Improve Influenza Vaccine Uptake May Be Less Effective in Patients With Diabetes

December 23rd 2023

Top 5 Most-Read Vaccine Content of 2023

December 18th 2023

Are Maternal Vaccines Effective Against Infant Influenza-Associated Hospitalizations?

December 14th 2023

What We’re Reading: Pneumococcal Disease Plunge; Health Care Spending; Mental Health Treatment Access

Video Interviews
View All
February 14th 2023

Dr Amy Crawford-Faucher Discusses the Future of Vaccination for COVID-19

February 7th 2023

Dr Amy Crawford-Faucher on Efforts to Get Childhood Immunizations Back on Track

February 3rd 2023

Dr Amy Crawford-Faucher Discusses RSV and Future Vaccines

Continuing Medical Education

More News

Child after vaccination | Image Credit: © iHumnoi - stock.adobe.com
December 12th 2023

Did the COVID-19 Pandemic Change Parental Vaccine Hesitancy in the United States?

Pearl Steinzor
Growing misinformation around COVID-19 vaccines may have resulted in changes in parents’ trust in vaccines.
Male nurse with mask giving vaccine to patient in clinic. | Zoran Zeremski - stock.adobe.com
December 5th 2023

Quadrivalent Influenza Vaccines Provide Higher Immunogenicity Against B Lineage vs Trivalent

Joshua Fitch
Overall, the study authors concluded that the immunogenicity of quadrivalent influenza vaccines (QIV) and trivalent inactivated influenza vaccines (TIV) was similar for common influenza ingredients for children ages 6 to 35 months.
Hand holding vial with vaccine against corona virus | Thaut Images - stock.adobe.com
November 21st 2023

Can the Flu Vaccine Protect Against Heart Attack?

Pearl Steinzor
A meta-analysis highlights the potential of influenza vaccination as an adjunctive strategy in reducing cardiovascular disease.
RSV vaccine vial with syringe - Respiratory syncytial virus shot | MargJohnsonVA - stock.adobe.com
November 16th 2023

CDC Releases Additional Doses of Nirsevimab-Alip for RSV Immunization in Infants

Pearl Steinzor
More than 77,000 additional doses of nirsevimab-alip will be distributed for respiratory syndactyl virus (RSV) immunization in infants.
On the tablet, a sheet of paper and stickers with the inscription - FOIA, THE FREEDOM OF INFORMATION ACT | Image Credit: Dzmitry - stock.adobe.com
November 14th 2023

Challenges in the US Vaccine Adverse Event Reporting System

Pearl Steinzor
A recent study sheds light on issues surrounding the system's functionality, transparency, and responsiveness.
Allergist doctor injects against allergies to a young girl, a medical. Allergen-specific immunotherapy, copy space | HENADZY - stock.adobe.com
November 7th 2023

Posters Present Improved Survival, Safety and Efficacy Results in IMM-101, LAB Vaccines

Pearl Steinzor
Researchers provide progression-free survival outcomes for a pancreatic cancer vaccine and safety and efficacy results for a peptide vaccine alone or in combination with pembrolizumab.
The doctor makes a revaccination of a pregnant girl against coronavirus and influenza. Prophylaxis | Image Credit: HENADZY - stock.adobe.com
November 4th 2023

Maternal COVID-19 Vaccination, Infection Boosts Infant Antibody Response

Alicia Bigica
Natural infection plus COVID-19 vaccination in pregnant mothers conferred more durable antibody responses in infants than natural infection alone.
Hand holding vial with vaccine against corona virus | Thaut Images - stock.adobe.com
November 2nd 2023

Pfizer, BioNTech Announce Data for mRNA-Based Combination Vaccine Program

Pearl Steinzor
The new vaccine program will protect against influenza and COVID-19.
what we're reading logo
October 27th 2023

What We’re Reading: Military Suicides Decrease; Paid Pregnancy Loss Leave; Positive Flu-COVID Shot Trial Results

AJMC Staff
The number of suicides among US military members and their families slightly decreased in 2022; Democratic lawmakers proposed legislation that would require employers to provide paid time off following a pregnancy loss; Pfizer and BioNTech’s flu–COVID-19 vaccine generated a strong immune response against strains of the viruses in an early- to mid-stage trial.
CDC Announces Shortage of Nirsevimab, Used for RSV
October 24th 2023

CDC Announces Shortage of Nirsevimab, Used for RSV

Julia Bonavitacola
Nirsevimab, a monoclonal antibody used to protect infants from respiratory syncytial virus (RSV), is in limited supply, according to a CDC announcement.
Syringe with blue vaccine, vial of medicine on green background. Vector illustration | Sylfida - stock.adobe.com
October 23rd 2023

No Association Found Between Vaccination, Risk of Hospitalization Due to MS Flare-Ups

Pearl Steinzor
Researchers evaluated the risk of hospitalization for severe flare-ups after vaccination in patients with multiple sclerosis (MS).
Doctor giving Covid vaccine to senior woman | Image credit: Rido - stock.adobe.com
October 12th 2023

COVID-19, Flu, and RSV Vaccine Skepticism Still an Issue Among Many Americans

Killian Meara
During a podcast hosted by Permanente Medicine, Sandra Fryhofer, MD, chair-elect of the Board of Trustees for the American Medical Association and a liaison to the CDC’s Advisory Committee on Immunization Practices, discussed the importance of vaccines for the fall and winter seasons.
Healthcare cure concept with a hand in blue medical gloves holding Coronavirus, Covid 19 virus, vaccine vial | Image credit: Leigh Prather - stock.adobe.com
October 9th 2023

Partisanship Remains a Key Predictor of COVID-19 Perspectives, Vaccinations

Pearl Steinzor
Patterns in COVID-19 vaccinations remain largely divided along political party lines, according to one report.
WWR logo
October 6th 2023

What We’re Reading: Counterfeit Weight Loss Drugs; COVID-19–Flu Vaccine Enters Phase 3 Trial; CMS Limits Predictive Software Use

AJMC Staff
FDA is investigating fraudulent schemes trafficking counterfeit semaglutide (Ozempic); Moderna plans to begin a late-stage trial of its combined COVID-19 and flu vaccine later this year; CMS will begin restricting predictive software used by insurance companies next year.
Scientists Whose Work on mRNA Allowed Development of COVID-19 Vaccines Win Nobel Prize
October 2nd 2023

Scientists Whose Work on mRNA Allowed Development of COVID-19 Vaccines Win Nobel Prize

Mary Caffrey
Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."
AJMC
September 20th 2023

Comment on COVID-19 Vaccine Hesitancy and Health Literacy

Amnuay Kleebayoon, PhD Viroj Wiwanitkit, MD
This letter discusses COVID-19 vaccine hesitancy and health literacy.
Site Logo
June 6th 2023

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

Hadii M. Mamudu, PhD, MPA Manik Ahuja, PhD Esther Adeniran, DrPH Adekunle Oke, MD, DrPH Bridget Hamilton, MPH KariLynn Dowling-McClay, PharmD, MPH Rebecca A. Fletcher, PhD David W. Stewart, PharmD JoAnne Collins, MPH Janet Keener, EdD Timir K. Paul, MD, PhD Florence M. Weierbach, PhD, MPH, RN
COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.
Person receiving vaccine
March 22nd 2023

Study Finds Vaccine Effectiveness Lowers as Time Increases From Last Dose

Julia Bonavitacola
Protection against COVID-19 and vaccine effectiveness increased after receiving 1 or 2 booster doses compared with a primary series alone, but vaccine effectiveness generally declined as the time since last dose increased.
Person on computer
March 19th 2023

Chatbot Systems Using AI May Feasibly Provide Access to Information on Infectious Diseases

Julia Bonavitacola
A recent study found that chatbot systems that used artificial intelligence (AI) could be valuable in providing access to current, accurate, and complete information about infectious diseases and vaccines against them.
image representing cost of Part B drugs
March 15th 2023

Biden Administration Releases Drug Rebate List, Promotes End of Vaccine Cost Sharing

Allison Inserro
The Biden administration released the list of 27 Medicare Part B drugs that are subject to rebates back to the government for having price increases that rose faster than inflation as well as the removal of out-of-pocket costs for some vaccines covered under Part D.
Virus
March 13th 2023

Contact Heterogeneity Could Produce Negative Vaccine Efficiency

Julia Bonavitacola
In this new study, vaccine efficiency calculations were determined by the amount of heterogeneous and homogenous contact had by vaccinated individuals.
Vaccine
March 10th 2023

Antibody Response to Omicron Variant Reduced 8 Months After COVID-19 Vaccination

Julia Bonavitacola
A study of Navy sailors and Marines from the United States found that only 7.7% of participants had neutralizing antibodies for the Omicron variant 8 months after vaccination.
Vaccine
March 6th 2023

Latent Cytomegalovirus Affects Vaccine Response to COVID-19

Julia Bonavitacola
A recent study found that a latent cytomegalovirus infection can have a negative effect on mRNA vaccine responsiveness to COVID-19 infection.
How Community-Based Organizations Can Help Address Vaccine Disparities
March 1st 2023

How Community-Based Organizations Can Help Address Vaccine Disparities

Julia Bonavitacola
A recent study found that understanding and engaging with community-based organizations could help public health officials and care providers disperse accurate information and address disparities surrounding COVID-19 and routine immunizations.
Pregnant stomach
February 27th 2023

COVID-19 Vaccine Not Associated With Adverse Outcomes in Pregnant Women

Julia Bonavitacola
A review found that adverse neonatal and maternal outcomes were not associated with COVID-19 vaccination during pregnancy.
Person receiving vaccine
February 21st 2023

Vaccine Hesitancy Abated With Interactive Risk Ratio Simulation

Julia Bonavitacola
A new study has found that adults who were vaccine hesitant were more likely to show a positive change in opinion when presented with an interactive risk ratio simulation.
What We’re Reading: Social Security, Medicare Warnings; FDA Experts Back OTC Naloxone; Moderna’s COVID-19 Vaccines Stay Free
February 16th 2023

What We’re Reading: Social Security, Medicare Warnings; FDA Experts Back OTC Naloxone; Moderna’s COVID-19 Vaccines Stay Free

AJMC Staff
Social Security and Medicare spending could double by 2023; FDA panel experts want naloxone to be available over the counter after the drug information is revised; Moderna announced its COVID-19 vaccines will stay free, and the Biden administration might keep tests and treatments free for the uninsured.
Older adult receiving vaccine
February 13th 2023

Protection From COVID-19 Infection With Omicron Variant Waned After 6 Months

Julia Bonavitacola
A new study found that protection from the Omicron variant waned 6 months after the second dose of a COVID-19 vaccine in older patients.
Vaccine with syringe bottle
February 9th 2023

Adult Immunization Recommendations Receive Update for 2023

Julia Bonavitacola
The Advisory Committee on Immunization Practices released the update to the Recommended Adult Immunization Schedule for all US residents aged 19 years and older, which has been approved by the CDC and medical groups.
Patients Receiving Organ Transplants Undervaccinated Against Influenza, Pneumococcus
February 1st 2023

Patients Receiving Organ Transplants Undervaccinated Against Influenza, Pneumococcus

Julia Bonavitacola
Vaccination rates against influenza and pneumococcus were lower in patients receiving organ transplants who lived outside of urban areas and had lower socioeconomic status.
12>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo